Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.
Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
Gut Liver. 2018 May 15;12(3):271-277. doi: 10.5009/gnl17138.
BACKGROUND/AIMS: Rebleeding is associated with mortality in patients with peptic ulcer bleeding (PUB), and risk stratification is important for the management of these patients. The purpose of our study was to examine the risk factors associated with rebleeding in patients with PUB.
The Korean Peptic Ulcer Bleeding registry is a large prospectively collected database of patients with PUB who were hospitalized between 2014 and 2015 at 28 medical centers in Korea. We examined the basic characteristics and clinical outcomes of patients in this registry. Univariate and multivariate analyses were performed to identify the factors associated with rebleeding.
In total, 904 patients with PUB were registered, and 897 patients were analyzed. Rebleeding occurred in 7.1% of the patients (64), and the 30-day mortality was 1.0% (nine patients). According to the multivariate analysis, the risk factors for rebleeding were the presence of co-morbidities, use of multiple drugs, albumin levels, and hematemesis/hematochezia as initial presentations.
The presence of co-morbidities, use of multiple drugs, albumin levels, and initial presentations with hematemesis/hematochezia can be indicators of rebleeding in patients with PUB. The wide use of proton pump inhibitors and prompt endoscopic interventions may explain the low incidence of rebleeding and low mortality rates in Korea.
背景/目的:在消化性溃疡出血(PUB)患者中,再出血与死亡率相关,对这些患者进行风险分层非常重要。我们的研究目的是探讨与 PUB 患者再出血相关的危险因素。
韩国消化性溃疡出血注册登记研究是一项前瞻性收集的数据库研究,纳入了 2014 年至 2015 年期间韩国 28 家医疗中心住院的 PUB 患者。我们检查了该登记研究中患者的基本特征和临床结局。进行单因素和多因素分析,以确定与再出血相关的因素。
共纳入 904 例 PUB 患者,其中 897 例进行了分析。7.1%(64 例)的患者发生再出血,30 天死亡率为 1.0%(9 例)。多因素分析显示,合并症、多种药物使用、白蛋白水平和呕血/黑便作为初始表现是再出血的危险因素。
合并症、多种药物使用、白蛋白水平和初始表现为呕血/黑便可能是 PUB 患者再出血的预测指标。质子泵抑制剂的广泛使用和及时的内镜干预可能解释了韩国再出血发生率低和死亡率低的原因。